SUPN logo

Supernus Pharmaceuticals (SUPN) Long Term Liabilities

Annual Total Long Term Liabilities

$39.94 M
-$26.02 M-39.44%

December 31, 2024


Summary


Performance

SUPN Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSUPNbalance sheetmetrics:

Quarterly Long Term Liabilities

$39.94 M
-$4.10 M-9.31%

December 31, 2024


Summary


Performance

SUPN Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSUPNbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

SUPN Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-39.4%0.0%
3 y3 years-92.8%-53.3%
5 y5 years-90.1%-53.3%

SUPN Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-92.8%at low-92.8%at low
5 y5-year-92.8%at low-92.8%at low
alltimeall time-92.8%+197.3%-92.8%+270.5%

Supernus Pharmaceuticals Long Term Liabilities History

DateAnnualQuarterly
Dec 2024
$39.94 M(-39.4%)
$39.94 M(-9.3%)
Sep 2024
-
$44.04 M(-11.4%)
Jun 2024
-
$49.72 M(-17.6%)
Mar 2024
-
$60.37 M(-8.5%)
Dec 2023
$65.96 M(-48.6%)
$65.96 M(-22.8%)
Sep 2023
-
$85.44 M(-29.2%)
Jun 2023
-
$120.60 M(-18.6%)
Mar 2023
-
$148.11 M(+15.4%)
Dec 2022
$128.35 M(-77.0%)
$128.35 M(+12.2%)
Sep 2022
-
$114.34 M(-3.1%)
Jun 2022
-
$118.00 M(-77.6%)
Mar 2022
-
$526.51 M(-5.6%)
Dec 2021
$557.92 M(+8.5%)
$557.92 M(+9.4%)
Sep 2021
-
$509.86 M(+1.2%)
Jun 2021
-
$504.03 M(-1.6%)
Mar 2021
-
$512.19 M(-0.4%)
Dec 2020
$514.14 M(+27.2%)
$514.14 M(+2.5%)
Sep 2020
-
$501.54 M(-9.8%)
Jun 2020
-
$555.77 M(+36.2%)
Mar 2020
-
$408.15 M(+1.0%)
Dec 2019
$404.27 M(+11.2%)
$404.27 M(+1.1%)
Sep 2019
-
$399.94 M(+0.8%)
Jun 2019
-
$396.80 M(+0.8%)
Mar 2019
-
$393.72 M(+8.3%)
Dec 2018
$363.44 M(+969.4%)
$363.44 M(+0.3%)
Sep 2018
-
$362.23 M(+1.1%)
Jun 2018
-
$358.37 M(+1.2%)
Mar 2018
-
$354.20 M(+942.3%)
Dec 2017
$33.98 M
$33.98 M(+17.8%)
DateAnnualQuarterly
Sep 2017
-
$28.86 M(-8.2%)
Jun 2017
-
$31.45 M(-8.0%)
Mar 2017
-
$34.19 M(-7.8%)
Dec 2016
$37.07 M(-15.1%)
$37.07 M(-7.5%)
Sep 2016
-
$40.10 M(+233.1%)
Jun 2016
-
$12.04 M(-1.4%)
Mar 2016
-
$12.21 M(-72.0%)
Dec 2015
$43.69 M(-35.7%)
$43.69 M(+207.5%)
Sep 2015
-
$14.21 M(-7.7%)
Jun 2015
-
$15.39 M(-15.4%)
Mar 2015
-
$18.20 M(-73.2%)
Dec 2014
$67.96 M(+32.9%)
$67.96 M(+78.5%)
Sep 2014
-
$38.08 M(-8.5%)
Jun 2014
-
$41.63 M(+0.6%)
Mar 2014
-
$41.41 M(-19.0%)
Dec 2013
$51.13 M(+280.6%)
$51.13 M(-40.7%)
Sep 2013
-
$86.24 M(+7.7%)
Jun 2013
-
$80.06 M(+642.6%)
Mar 2013
-
$10.78 M(-19.8%)
Dec 2012
$13.44 M(-47.3%)
$13.44 M(-24.5%)
Sep 2012
-
$17.79 M(-11.5%)
Jun 2012
-
$20.10 M(-12.7%)
Mar 2012
-
$23.02 M(-9.8%)
Dec 2011
$25.52 M(-66.5%)
$25.52 M(-71.1%)
Sep 2011
-
$88.32 M(+16.0%)
Dec 2010
$76.12 M(+0.1%)
$76.12 M(+0.1%)
Sep 2010
-
$76.01 M(-0.0%)
Dec 2009
$76.02 M(+0.5%)
$76.02 M
Dec 2008
$75.61 M
-

FAQ

  • What is Supernus Pharmaceuticals annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals annual total long term liabilities year-on-year change?
  • What is Supernus Pharmaceuticals quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals quarterly long term liabilities year-on-year change?

What is Supernus Pharmaceuticals annual total long term liabilities?

The current annual total long term liabilities of SUPN is $39.94 M

What is the all time high annual total long term liabilities for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high annual total long term liabilities is $557.92 M

What is Supernus Pharmaceuticals annual total long term liabilities year-on-year change?

Over the past year, SUPN annual total long term liabilities has changed by -$26.02 M (-39.44%)

What is Supernus Pharmaceuticals quarterly total long term liabilities?

The current quarterly long term liabilities of SUPN is $39.94 M

What is the all time high quarterly long term liabilities for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high quarterly total long term liabilities is $557.92 M

What is Supernus Pharmaceuticals quarterly long term liabilities year-on-year change?

Over the past year, SUPN quarterly total long term liabilities has changed by $0.00 (0.00%)